-
Vishal Mega Mart
129.95 134.50(%) -
Reliance Industr
1,425.80 1,115.55(%) -
Infosys
1,647.70 2,006.80(%) -
Sterlite Tech.
119.00 119.00(%) -
HDFC Bank
1,919.55 1,588.50(%) -
Varun Beverages
469.50 419.40(%) -
ICICI Bank
1,417.60 1,101.00(%) -
TCS
3,522.30 4,585.90(%) -
Happiest Minds
674.00 955.00(%) -
Mazagon Dock
3,342.85 3,778.00(%) -
Garden Reach Sh.
3,205.00 3,528.00(%) -
Bharti Airtel
1,847.50 1,373.05(%) -
M & M
2,993.70 2,360.45(%) -
Kotak Mah. Bank
2,129.90 1,679.10(%) -
Tata Motors
672.00 542.55(%) -
Cochin Shipyard
2,244.10 2,977.10(%) -
Hind. Unilever
2,334.10 3,034.50(%) -
Sun Pharma.Inds.
1,641.40 1,461.40(%) -
St Bk of India
790.75 679.65(%) -
HCL Technologies
1,738.00 2,011.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Suven Life Sciences Ltd Miscellaneous
- Indian Private
- BSE Code : 4916.0
- ISIN : INE495B01038
-
Today’s Low
236.05 -
Today’s High
248.40

-
Open
248.00 -
Perv Close
248.48 -
52W Low
95.20 -
52W High
271.72
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
5,167.26
-
Div & Yield %
0.00
-
Book Value(₹)
36.66
-
Debt-Equity Ratio
-4.64
-
AGM Date
17-Jun-2025
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.00
-
Mar.Cap (₹Cr.)
5,167.26
-
RONW (%)
0.00
-
ROCE (%)
0.00
Score Board
-
Equity (₹ in Cr.)
21.81
-
BV (₹)
36.70
-
Sales( ₹ in Cr.)
6.66
-
NP (in Cr.)
-47.08
-
NP Var(%)
-135.0
-
Div%
0.0
-
CPS (₹)
-1.90
-
EPS (₹)
-2.20
-
Traded Value (₹ in Lakhs)
5,428.95
-
52 Week High
271.72
-
52 Week Low
95.20
-
Price BSE
249.0
-
Price NSE
248.00
-
Market Capital( in Cr.)
5,428.95
-
P/C Ratio
-131.60
-
P/E Ratio
-115.30
-
Price Vs.BV
-2.20
-
14-May-2025( 11:52)
Corporate News - Suven... - Suven Life Sciences announced...
-
14-May-2025( 11:52)
Corporate News - Suven... - Suven Life Sciences announced...
-
13-May-2025( 01:52)
Results - Announcements - Suven... - Net Loss of Suven Life Science...
-
07-May-2025( 10:54)
Corporate News - Suven... - Suven Life Sciences will hold...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 11.69 | 13.54 | 11.84 | 13.48 | 14.41 | 285.67 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 11.69 | 13.54 | 11.84 | 13.48 | 14.41 | 285.67 |
Other Income | 28.59 | 14.45 | 5.32 | 7.75 | 14.04 | 27.25 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.29 |
Total Income | 40.28 | 27.99 | 17.16 | 21.23 | 28.45 | 322.21 |
EXPENDITURE : | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 79.62 |
Power and Fuel Cost | 0.26 | 0.00 | 0.00 | 0.00 | 1.63 | 19.37 |
Employee Cost | 16.53 | 15.77 | 17.46 | 15.29 | 14.60 | 33.85 |
Other Manufacturing Expenses | 1.54 | 0.93 | 2.59 | 0.14 | 0.02 | 29.81 |
Selling and Administration Expenses | 23.06 | 22.95 | 27.01 | 27.61 | 30.26 | 75.60 |
Miscellaneous Expenses | 1.15 | 1.52 | 1.30 | 0.89 | 3.17 | 8.02 |
Employee Benefit Expenses | 16.53 | 15.77 | 17.46 | 15.29 | 14.60 | 33.85 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 42.55 | 41.18 | 48.37 | 43.93 | 49.68 | 246.26 |
Operating Profit | -2.27 | -13.18 | -31.22 | -22.70 | -21.23 | 75.94 |
Interest | 0.24 | 0.40 | 0.64 | 0.91 | 0.54 | 1.90 |
Gross Profit | -2.51 | -13.58 | -31.86 | -23.61 | -21.77 | 74.04 |
Depreciation | 6.50 | 6.54 | 4.39 | 4.35 | 4.17 | 10.79 |
Profit Before Tax | -9.01 | -20.12 | -36.25 | -27.96 | -25.94 | 63.25 |
Current Tax | -1.00 | 0.00 | 0.00 | 0.38 | 2.28 | 12.99 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | -5.70 | -14.46 | 11.07 |
Reported Net Profit | -8.01 | -20.13 | -36.25 | -22.63 | -13.75 | 39.19 |
Extraordinary Items | 12.01 | 7.79 | 3.99 | 0.06 | 0.50 | 12.89 |
Adjusted Net Profit | -20.02 | -27.92 | -40.24 | -22.69 | -14.25 | 26.30 |
Adjustment below Net Profit | -0.06 | 0.19 | -0.15 | -0.31 | -0.30 | -319.86 |
P & L Balance brought forward | 141.49 | 161.43 | 197.83 | 220.77 | 234.82 | 515.49 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | 133.43 | 141.49 | 161.43 | 197.83 | 220.77 | 234.82 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 150.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 |
Earnings Per Share-Unit Curr | -0.37 | -0.92 | -2.49 | -1.78 | -1.08 | 3.08 |
Earnings Per Share(Adj)-Unit Curr | -0.37 | -0.92 | -2.29 | -1.64 | -1.00 | 0.14 |
Book Value | 38.77 | 39.14 | 32.74 | 28.66 | 30.46 | 31.56 |
Book Value(Adj)-Unit Curr | 38.77 | 39.14 | 30.17 | 26.41 | 28.07 | 1.47 |